Descriptive profile of PIK3CA-mutated colorectal cancer in postmenopausal women

被引：0
|
作者：
Amanda I. Phipps
Karen W. Makar
Polly A. Newcomb
机构：
[1] Fred Hutchinson Cancer Research Center,Public Health Sciences Division
[2] Fred Hutchinson Cancer Research Center,Public Health Sciences Division
来源：
International Journal of Colorectal Disease | 2013年 / 28卷
关键词：
Colorectal cancer; PIK3CA; Survival; KRAS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1637 / 1642
页数：5
相关论文
共 50 条
  • [1] Descriptive profile of PIK3CA-mutated colorectal cancer in postmenopausal women
    Phipps, Amanda I.
    Makar, Karen W.
    Newcomb, Polly A.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2013, 28 (12) : 1637 - 1642
  • [2] Aspirin for PIK3CA-mutated colorectal cancer
    Gilbert, Judith A.
    LANCET ONCOLOGY, 2012, 13 (12): : E522 - E522
  • [3] Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
    Daniella C. N. Hall
    Ralf A. Benndorf
    Cellular and Molecular Life Sciences, 2022, 79
  • [4] Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
    Hall, Daniella C. N.
    Benndorf, Ralf A.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (07)
  • [5] Alpelisib for PIK3CA-Mutated Advanced Breast Cancer
    Park, Jewel
    Shin, Sang W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (07): : 686 - 686
  • [6] Perifosine enhances sensitivity of oxaliplatin and 5-fluorourasil in PIK3CA-mutated colorectal cancer
    Yamamoto, Yuuta
    Tsubaki, Masanobu
    Takeda, Tomoya
    Seki, Shiori
    Nishida, Shozo
    CANCER SCIENCE, 2021, 112 : 908 - 908
  • [7] ALPELISIB FOR RECURRENT PIK3CA-MUTATED RECURRENT CERVCIAL CANCER
    Bogani, G.
    Indini, A.
    Bini, M.
    Raspagliesi, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A1 - A1
  • [8] Alpelisib plus fulvestrant for PIK3CA-mutated breast cancer
    Stirrups, Robert
    LANCET ONCOLOGY, 2019, 20 (07): : E347 - E347
  • [9] Cell line models for drug discovery in PIK3CA-mutated colorectal cancers
    Voutsadakis, Ioannis A.
    MEDICAL ONCOLOGY, 2022, 39 (05)
  • [10] Perifosine overcome MEK inhibitor resistance in PIK3CA-mutated colorectal carcinoma
    Yamamoto, Yuuta
    Tsubaki, Masanobu
    Takeda, Tomoya
    Matsuda, Takuya
    Kimura, Akihiro
    Nishida, Shozo
    CANCER SCIENCE, 2022, 113 : 1050 - 1050
12345